Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 28% ± 14% | |
glutamatergic neuron | 13 studies | 53% ± 27% | |
pericyte | 13 studies | 28% ± 13% | |
microglial cell | 12 studies | 27% ± 13% | |
fibroblast | 11 studies | 30% ± 8% | |
GABAergic neuron | 10 studies | 53% ± 23% | |
astrocyte | 10 studies | 30% ± 16% | |
oligodendrocyte | 10 studies | 30% ± 15% | |
oligodendrocyte precursor cell | 9 studies | 30% ± 10% | |
epithelial cell | 8 studies | 34% ± 19% | |
macrophage | 8 studies | 29% ± 10% | |
smooth muscle cell | 8 studies | 28% ± 10% | |
ciliated cell | 7 studies | 29% ± 12% | |
neuron | 6 studies | 37% ± 13% | |
interneuron | 6 studies | 60% ± 28% | |
basal cell | 6 studies | 30% ± 17% | |
endothelial cell of lymphatic vessel | 6 studies | 32% ± 11% | |
adipocyte | 5 studies | 22% ± 3% | |
mast cell | 5 studies | 19% ± 4% | |
dendritic cell | 5 studies | 21% ± 5% | |
club cell | 5 studies | 25% ± 8% | |
type II pneumocyte | 5 studies | 26% ± 8% | |
granule cell | 4 studies | 39% ± 25% | |
retinal ganglion cell | 4 studies | 46% ± 28% | |
B cell | 4 studies | 20% ± 4% | |
retinal pigment epithelial cell | 4 studies | 35% ± 15% | |
cardiac muscle cell | 4 studies | 21% ± 3% | |
lymphocyte | 4 studies | 28% ± 8% | |
retinal cone cell | 4 studies | 32% ± 17% | |
retina horizontal cell | 4 studies | 27% ± 15% | |
monocyte | 4 studies | 21% ± 2% | |
natural killer cell | 4 studies | 23% ± 4% | |
type I pneumocyte | 4 studies | 26% ± 7% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 0% | |
GABAergic interneuron | 3 studies | 59% ± 11% | |
GABAergic amacrine cell | 3 studies | 39% ± 16% | |
amacrine cell | 3 studies | 32% ± 11% | |
glycinergic amacrine cell | 3 studies | 32% ± 11% | |
hepatocyte | 3 studies | 45% ± 17% | |
abnormal cell | 3 studies | 26% ± 13% | |
ependymal cell | 3 studies | 49% ± 9% | |
myofibroblast cell | 3 studies | 31% ± 10% | |
T cell | 3 studies | 25% ± 2% | |
alveolar macrophage | 3 studies | 22% ± 6% | |
muscle cell | 3 studies | 39% ± 27% | |
mesothelial cell | 3 studies | 33% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1902.94 | 577 / 578 | 100% | 23.88 | 1155 / 1155 |
ovary | 100% | 2596.11 | 180 / 180 | 100% | 21.10 | 428 / 430 |
esophagus | 100% | 2198.29 | 1445 / 1445 | 99% | 29.33 | 182 / 183 |
thymus | 100% | 2242.28 | 653 / 653 | 99% | 24.35 | 601 / 605 |
stomach | 100% | 1294.73 | 359 / 359 | 99% | 17.47 | 284 / 286 |
brain | 99% | 1272.45 | 2626 / 2642 | 100% | 14.03 | 704 / 705 |
prostate | 100% | 2199.66 | 245 / 245 | 99% | 16.48 | 498 / 502 |
breast | 100% | 2231.82 | 459 / 459 | 99% | 17.49 | 1106 / 1118 |
uterus | 100% | 2888.02 | 170 / 170 | 99% | 22.66 | 454 / 459 |
intestine | 100% | 1904.27 | 966 / 966 | 99% | 15.23 | 521 / 527 |
bladder | 100% | 2524.90 | 21 / 21 | 99% | 18.97 | 498 / 504 |
adrenal gland | 100% | 2574.96 | 258 / 258 | 98% | 15.38 | 226 / 230 |
kidney | 100% | 1596.92 | 89 / 89 | 98% | 17.80 | 884 / 901 |
pancreas | 96% | 766.62 | 316 / 328 | 98% | 14.43 | 174 / 178 |
skin | 100% | 2747.40 | 1808 / 1809 | 94% | 15.38 | 442 / 472 |
liver | 97% | 739.56 | 220 / 226 | 67% | 5.50 | 272 / 406 |
adipose | 100% | 2318.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3954.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.19 | 29 / 29 |
spleen | 100% | 1498.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.78 | 1 / 1 |
muscle | 99% | 966.02 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1109.91 | 826 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 9.13 | 61 / 80 |
peripheral blood | 55% | 922.51 | 512 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0035098 | Cellular component | ESC/E(Z) complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0003677 | Molecular function | DNA binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | AEBP2 |
Protein name | AE binding protein 2 Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2) |
Synonyms | hCG_1811073 |
Description | FUNCTION: Acts as an accessory subunit for the core Polycomb repressive complex 2 (PRC2), which mediates histone H3K27 (H3K27me3) trimethylation on chromatin leading to transcriptional repression of the affected target gene . Plays a role in nucleosome localization of the PRC2 complex . . |
Accessions | H7BYT4 ENST00000266508.14 [Q6ZN18-2] A0A669KBC9 ENST00000673644.1 ENST00000512223.6 ENST00000538425.5 A0A669KBL4 F5GZR7 ENST00000541908.5 H0YH08 ENST00000398731.3 ENST00000673824.1 G5EA50 ENST00000360995.8 [Q6ZN18-3] Q6ZN18 ENST00000398864.7 [Q6ZN18-1] |